avoided an unlikely adverse event of major consequence to the patient (if it had occurred) avoided a likely adverse event of moderate to major consequence to patient (if it had occurred) safety check on drug therapy already prescribed or administered (high risk) Very safety check on drug therapy prior to prescribing or administering (high risk) Improved safety where a avoidance of missed or inappropriate doses (high risk if missed/administered) 3 Positive major risk to patient avoided unnecessary drug therapy avoided which is likely to have prevented an adverse drug reaction (high risk) Impact avoidance of potential adverse effects or risks (high risk) avoidance of potential drug interaction (high risk) avoidance of potential risk in pregnancy or breastfeeding or safer drug advised (high risk) avoidance of high risk contraindicated drug when problem not identified by enquirer / actively identified by MI – avoided an unlikely adverse event of life-threatening risk to patient (if it had occurred) Extremely avoided a likely adverse event of major or life-threatening risk to the patient (if it had occurred) Improved safety where an avoidance of missed doses (very high risk if missed) 4 Positive extreme risk to patient avoidance of a life threatening condition avoided Impact avoidance of detrimental effects on organ function avoidance of known teratogenic drug in pregnancy
3 Very Positive Impact Improved safety where a major risk to patient avoided avoided an unlikely adverse event of major consequence to the patient (if it had occurred) avoided a likely adverse event of moderate to major consequence to patient (if it had occurred) safety check on drug therapy already prescribed or administered (high risk) safety check on drug therapy prior to prescribing or administering (high risk) avoidance of missed or inappropriate doses (high risk if missed/administered) unnecessary drug therapy avoided which is likely to have prevented an adverse drug reaction (high risk) avoidance of potential adverse effects or risks (high risk) avoidance of potential drug interaction (high risk) avoidance of potential risk in pregnancy or breastfeeding or safer drug advised (high risk) avoidance of high risk contraindicated drug – when problem not identified by enquirer / actively identified by MI 4 Extremely Positive Impact Improved safety where an extreme risk to patient avoided avoided an unlikely adverse event of life-threatening risk to patient (if it had occurred) avoided a likely adverse event of major or life-threatening risk to the patient (if it had occurred) avoidance of missed doses (very high risk if missed) avoidance of a life threatening condition avoidance of detrimental effects on organ function avoidance of known teratogenic drug in pregnancy